Michael Skinner

Scripps Research Institute — United States

Medicine · Health Sciences

19h-index1.9kcitations35works7.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Treatment of Major Depression(5), Neurotransmitter Receptor Influence on Behavior(4), HIV/AIDS drug development and treatment(4), Nausea and vomiting management(4), Tuberculosis Research and Epidemiology(3)

Publications35 total

A reverse translational study of PPAR-α agonist efficacy in human and rodent models relevant to alcohol use disorder
Neurobiology of Stress·2024· 7 citedOpen Access
Preclinical and clinical evidence for suppression of alcohol intake by apremilast
Journal of Clinical Investigation·2023· 58 citedOpen Access
The FDA-approved drug apremilast suppresses alcohol intake: clinical and pre-clinical validation
2021· 5 citedOpen Access
Performance of a FRET-Based Point-of-Care Immunoassay for the Quantitation of Fecal Calprotectin
2021· 3 citedOpen Access
Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine
Clinical Pharmacokinetics·2010· 45 cited
Accurate Neurovision Electrode Placement for Recurrent Laryngeal Nerve Monitoring During Neck Surgery
Anesthesia & Analgesia·2009
Safety, Tolerability, and Changes in Amyloid β Concentrations After Administration of a γ-Secretase Inhibitor in Volunteers
Clinical Neuropharmacology·2005· 214 cited
Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects
International Journal of Clinical Pharmacology and Therapeutics·2005· 47 cited
A phase I and pharmacokinetic study of the nonpolyglutamatable thymidylate synthase inhibitor ZD9331 plus docetaxel in patients with advanced solid malignancies
Investigational New Drugs·2004· 3 cited
P4-333 Safety, tolerability, and changes in plasma and cerebrospinal fluid amyloid beta concentrations after administration of a functional gamma-secretase inhibitor in healthy volunteers
Neurobiology of Aging·2004· 19 cited
Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers
British Journal of Clinical Pharmacology·2004· 25 citedOpen Access
Effect of age on the pharmacokinetics of duloxetine in women
British Journal of Clinical Pharmacology·2003· 69 citedOpen Access
METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
Drug Metabolism and Disposition·2003· 205 cited
Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers
Clinical Pharmacology & Therapeutics·2003· 189 cited
Thoracic Epidural Anesthesia for Cardiac Surgery: The Effects on Tracheal Intubation Time and Length of Hospital Stay
Anesthesia & Analgesia·2002· 131 cited
Thoracic Epidural Anesthesia for Cardiac Surgery: The Effects on Tracheal Intubation Time and Length of Hospital Stay
Anesthesia & Analgesia·2002· 110 cited
Nicardipine prevents cognitive impairment due to chronic hypertension
1997
A simple computer based system to analyze Morris water maze trials on-line
Journal of Neuroscience Methods·1996· 18 cited
Effects of Captopril and Propranolol on Cognitive Function and Cerebral Blood Flow in Aged Hypertensive Rats
The Journals of Gerontology Series A·1996· 18 citedOpen Access
The Clinical Pharmacokinetics of Rifabutin
Clinical Infectious Diseases·1996· 138 cited
page 1 of 2Next →

Frequent Co-authors

Terrence F. Blaschke(7), Mary Pat Knadler(6), Celedon Gonzales(5), Shobha Reddy(4), M. Großmann(4), Han‐Yi Kuan(3), Amanda J. Roberts(3), John M. Light(3), Susan Quello(3), Farhad F. Shadan(3), Barbara J. Mason(3), Dun‐Xian Tan(3), Eric Siemers(2), Robert A. Dean(2), Julie Satterwhite(2), Martin R. Farlow(2), Patrick C. May(2), Alan X. Pan(2), Stephen D. Wise(2), Mark Priestley(2)